Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Viewpoints: The impact of Florida's special election; drug testing for doctors; the toll from Alzheimer's

A rule of electoral politics is that when a Democratic wave is building, the media broadcast it like a foregone conclusion. When a Republican wave is building, Beltway pundits are the last to admit it. After Tuesday's GOP win in a Florida special House election, even the press corps now agrees that Republicans are poised for major gains in November, assuming the GOP has the wit to exploit it (3/12).

14 Mar 2014

Microvascular coronary dysfunction in women may be triggered by emotional stress, say researchers

Researchers at the Barbra Streisand Women's Heart Center at the Cedars-Sinai Heart Institute have found that emotional stressors - such as those provoking anger - may cause changes in the nervous system that controls heart rate and trigger a type of coronary artery dysfunction that occurs more frequently in women than men.

14 Mar 2014

FDA clears Toshiba’s CT Myocardial Perfusion technology

To improve cardiac diagnoses with simplified dose reduction technology, Toshiba announces the FDA clearance of its industry-exclusive CT Myocardial Perfusion capability. Available on Toshiba's AquilionTM ONE and Aquilion ONE ViSION Edition CT systems.

12 Mar 2014

Regado receives Fast Track designation from FDA for REG1

Regado Biosciences, Inc., a biopharmaceutical company focused on the development of actively controllable therapeutics, today announced that the United States Food and Drug Administration has designated REG1 for anticoagulant therapy to be used in patients with coronary artery disease during percutaneous coronary interventions (PCI) as a Fast Track development program.

10 Mar 2014

Safeguard Scientifics reports net income of $24 million for fourth quarter 2013

Safeguard Scientifics, Inc. today announced fourth quarter and full-year 2013 financial results. For the three months ended December 31, 2013, Safeguard's net income was $24.0 million, or $1.10 per share, compared to net loss of $10.8 million, or $0.51 per share for the same period in 2012. For the year ended December 31, 2013, Safeguard's net loss was $35.5 million, or $1.66 per share, compared to $39.4 million, or $1.88 per share for the same period in 2012.

6 Mar 2014

EU study analyzes effectiveness of cardiac computed tomography

Scientists from 28 research facilities in 20 European countries are meeting today in Berlin to kick off the collaborative research project DISCHARGE. The purpose of this project is to determine for which patients with chest pain cardiac CT or cardiac catheterization is best suited.

14 Feb 2014

Loving relationship is good for heart, says cardiologist

With Valentine's Day just one day away, Vanderbilt Heart and Vascular Institute cardiologist Julie Damp, M.D., says being involved in a healthy, loving relationship is good for the heart.

14 Feb 2014

Tryton Medical received CE Mark for treatment of Left Main Coronary artery disease

Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, announced that it has received CE Mark for the treatment of Left Main Coronary artery disease. With this approval, Tryton Medical becomes the first company to earn a CE Mark for this indication.

13 Feb 2014

Bosch Healthcare receives NCQA's Disease Management certification for HMPs

Robert Bosch Healthcare Systems, Inc., the market leader in evidence-based telehealth solutions, today announced the that it has received certification for program design in Disease Management for 16 Health Management Programs (HMPs) that it submitted to the National Committee for Quality Assurance.

10 Feb 2014

TV series House helps doctors diagnose Cobalt intoxication of patient with hip replacement

In today’s edition of The Lancet [Friday 7 February], doctors report the case of a patient with severe heart failure, who in May 2012 was referred to the Marburg University clinic in Germany.

10 Feb 2014

Researchers make first link between menopause, smoking and genetic variations in white women

New research is lighting up yet another reason for women to quit smoking. In a study published online in the journal Menopause, researchers from the Perelman School of Medicine at the University of Pennsylvania report the first evidence showing that smoking causes earlier signs of menopause - in the case of heavy smokers, up to nine years earlier than average - in white women with certain genetic variations.

5 Feb 2014

Sanford Hospital starts clinical trial to study dissolving device in patients with CAD

Sanford Heart Hospital has started a clinical trial to study a dissolving device in patients with coronary artery disease. The ABSORB III clinical trial will investigate the safety and effectiveness of the Absorb Bioresorbable Vascular Scaffold (BVS) device, manufactured by global health care company Abbott.

4 Feb 2014

Prediction models can be useful for heart team to determine best treatment strategy

Detailed prediction models that project long-term patient mortality following percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) surgery can be useful for the heart team when determining the best treatment strategy for individual patients, according to a study in the February 2014 issue of The Annals of Thoracic Surgery.

31 Jan 2014

Heart transplantation continues to be "gold standard" treatment for end-stage heart failure

Heart transplantation continues to be the "gold standard" treatment for end-stage heart failure, and a large number of patients now live 20 years or more after surgery, according to a study in the February 2014 issue of The Annals of Thoracic Surgery.

30 Jan 2014

Aspirin prescribed more often for stroke prevention in AF despite of dangerous side effects

Aspirin is still overprescribed for stroke prevention in atrial fibrillation (AF) despite the potential for dangerous side effects, according to research published today.

29 Jan 2014

Children who undergo heart transplantation experience good outcomes

Infants and children who undergo heart transplantation are experiencing good outcomes after surgery and may expect to live beyond 15 years post-surgery with reasonable cardiac function and quality of life, according to a study released today at the 50th Annual Meeting of The Society of Thoracic Surgeons.

28 Jan 2014

Cleveland Clinic: Process that turns HDL cholesterol bad discovered

Cleveland Clinic researchers have discovered the process by which high-density lipoprotein (HDL) - the so-called "good cholesterol" - becomes dysfunctional, loses its cardio-protective properties, and instead promotes inflammation and atherosclerosis, or the clogging and hardening of the arteries.

26 Jan 2014

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Viewpoints: The impact of Florida's special election; drug testing for doctors; the toll from Alzheimer's

Microvascular coronary dysfunction in women may be triggered by emotional stress, say researchers

FDA clears Toshiba’s CT Myocardial Perfusion technology

Regado receives Fast Track designation from FDA for REG1

Safeguard Scientifics reports net income of $24 million for fourth quarter 2013

EU study analyzes effectiveness of cardiac computed tomography

Loving relationship is good for heart, says cardiologist

Tryton Medical received CE Mark for treatment of Left Main Coronary artery disease

Bosch Healthcare receives NCQA's Disease Management certification for HMPs

TV series House helps doctors diagnose Cobalt intoxication of patient with hip replacement

Researchers make first link between menopause, smoking and genetic variations in white women

Sanford Hospital starts clinical trial to study dissolving device in patients with CAD

Prediction models can be useful for heart team to determine best treatment strategy

Heart transplantation continues to be "gold standard" treatment for end-stage heart failure

Aspirin prescribed more often for stroke prevention in AF despite of dangerous side effects

Children who undergo heart transplantation experience good outcomes

Cleveland Clinic: Process that turns HDL cholesterol bad discovered

Morbidity following liver transplant is highest among obese patients with diabetes

New easy-to-use risk calculator helps predict heart failure patients' chances of survival

Clinical rule stratifies CAP patients’ cardiac risk

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Newsletters you may be interested in